Parsippany, New Jersey. Edenbridge Pharmaceuticals, LLC is pleased to announce the launch of Pantoprazole Sodium for Delayed-Release Oral Suspension, a generic version of Protonix®* for delayed-release oral suspension. Pantoprazole Sodium for Delayed-Release Oral Suspension is indicated for the short-term treatment in the healing and symptomatic relief of erosive esophagitis (EE), for maintenance of healing of EE and reduction in relapse rates of daytime and nighttime heartburn symptoms in adult patients with GERD, and for the long-term treatment of pathological hypersecretory conditions, including Zollinger-Ellison Syndrome. For more information, please contact the Company directly at info@dexcelpharmausa.com
Pantoprazole Sodium for Delayed-Release Oral Suspension Launch
Specialty Products
To learn more about our specialty products, vigabatrin and Yargesa®, and how you may be able to save, please visit the Products page or navigate to a product-specific page.
Specialty Products
To learn more about our specialty products, vigabatrin and Yargesa®, and how you may be able to save, please visit the Products page or navigate to a product-specific page.